Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Francis Murigi
Introduction
Francis Murigi is a notable inventor based in Germantown, MD (US). He has made significant contributions to the field of cancer research through his innovative work in synthesizing novel galeterone analogs. His research focuses on developing compounds that exhibit multi-target anticancer activities.
Latest Patents
Francis Murigi holds a patent for a "Method for production of novel galeterone analogs and uses thereof." This patent highlights the importance of galeterone and its C-3 analogs, which are of substantial interest due to their anticancer properties. The patent provides novel procedures for the gram-scale, high-yield synthesis of C-3 analogs of galeterone, including 3β-(1H-imidazole-1-yl)-17-(1H-benzimidazole-1-yl)-androsta-5,16-diene (galeterone 3β-imidazole) and 3β-(pyridine-4-ylmethoxy)-17-(1H-benzimidazol-1-yl)androsta-5,16-diene (galeterone 3β-pyridine methoxylate). He has 1 patent to his name.
Career Highlights
Francis Murigi is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution allows him to contribute to groundbreaking research in the field of oncology.
Collaborations
Some of his notable coworkers include Vincent C O Njar and Purushottamachar Puranik. Their collaborative efforts enhance the research environment and foster innovation in cancer treatment.
Conclusion
Francis Murigi's contributions to the field of cancer research through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic options in the fight against cancer.